Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $2.87 Million - $4.89 Million
15,011 Added 131.64%
26,414 $8.6 Million
Q4 2023

Feb 07, 2024

SELL
$160.99 - $215.69 $8.7 Million - $11.7 Million
-54,056 Reduced 82.58%
11,403 $2.17 Million
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $9.24 Million - $13.5 Million
-47,540 Reduced 42.07%
65,459 $13 Million
Q2 2023

Aug 09, 2023

BUY
$223.05 - $302.68 $20,520 - $27,846
92 Added 0.08%
112,999 $32.3 Million
Q1 2023

May 11, 2023

BUY
$175.41 - $217.92 $4.98 Million - $6.19 Million
28,400 Added 33.61%
112,907 $24.5 Million
Q4 2022

Feb 10, 2023

SELL
$204.38 - $296.82 $2.3 Million - $3.34 Million
-11,269 Reduced 11.77%
84,507 $17.4 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $922,757 - $1.47 Million
-4,727 Reduced 4.7%
95,776 $26.6 Million
Q2 2022

Aug 10, 2022

BUY
$115.91 - $214.48 $11.6 Million - $21.6 Million
100,503 New
100,503 $19.2 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.